IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $221,000 | -33.6% | 20 | 0.0% | 0.00% | – |
| Q1 2022 | $333,000 | -12.8% | 20 | 0.0% | 0.00% | – |
| Q4 2021 | $382,000 | -22.5% | 20 | 0.0% | 0.00% | – |
| Q3 2021 | $493,000 | -0.4% | 20 | 0.0% | 0.00% | – |
| Q2 2021 | $495,000 | -21.8% | 20 | 0.0% | 0.00% | – |
| Q1 2021 | $633,000 | -31.8% | 20 | 0.0% | 0.00% | – |
| Q4 2020 | $928,000 | +41.0% | 20 | 0.0% | 0.00% | – |
| Q3 2020 | $658,000 | +19.9% | 20 | 0.0% | 0.00% | – |
| Q2 2020 | $549,000 | -8.3% | 20 | 0.0% | 0.00% | – |
| Q1 2020 | $599,000 | +26.6% | 20 | 0.0% | 0.00% | – |
| Q4 2019 | $473,000 | -93.4% | 20 | -94.9% | 0.00% | -100.0% |
| Q3 2019 | $7,169,000 | -96.3% | 394 | -94.9% | 0.00% | -97.1% |
| Q2 2019 | $191,183,000 | – | 7,800 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |